Therapeutic and Radiosensitizing Effects of Armillaridin on Human Esophageal Cancer Cells
Figure 2
The morphology of esophageal cancer cells treated by Armillaridin. Cells were treated with a vehicle as control (left) or Armillaridin 10 M for 3 days (right). (a) CE81T/VGH squamous carcinoma cells. (b) BE-3 adenocarcinoma cells.
